Sepsis and acute respiratory distress syndrome study in China
Treatments studied
Part of Infections clinical trials.
This study looks at patients with sepsis (a severe infection that affects organs) and acute respiratory distress syndrome (ARDS, a serious lung condition) to learn more about these illnesses and improve care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years old or older.
- You must have been diagnosed with sepsis or acute respiratory distress syndrome (ARDS).
- You must be in the hospital in an intensive care unit (ICU) or similar unit at a participating hospital in China.
- You (or your legally authorized representative) must agree to join the study, or consent may be deferred if allowed by local rules.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at the early changes in the lungs of people with sepsis who develop a severe breathing problem called ARDS. Researchers will collect small samples of lung fluid to better understand the condition and potentially improve future treatments.
This trial studies people with and without sepsis in the ICU to understand why some get very sick from infections. It aims to find better ways to predict who will have complications and guide treatment.
This study collects blood samples from people in the ICU with sudden heart or lung problems caused by inflammation. The goal is to learn more about these conditions and improve future treatments.
This trial tests a new medicine called YD0743 for people who have both sepsis (a serious infection) and ARDS (a severe lung injury from the infection). The goal is to see if the medicine helps improve breathing and survival.
This study collects information from adult patients hospitalized with sepsis to better understand how sepsis affects people in China. By joining, you'll help researchers learn more about this condition to improve future care.
This study follows patients who had severe pneumonia or acute respiratory distress syndrome (ARDS) in the intensive care unit (ICU) to understand how they recover over time. It aims to identify factors that affect recovery trajectories.
Hear when a new Sepsis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.